NANCY WISNEWSKI

Profile

First Name

: NANCY

Middle Name

:

Last Name

: WISNEWSKI

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
OVER $100,000,000 
Equity 
2020-03-30 
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
Equity 
2013-02-24